NCT03073824 is a NA clinical trial of vSculpt in Pelvic Floor Disorders, sponsored by Joylux, Inc..

Who is sponsoring NCT03073824?

NCT03073824 is sponsored by Joylux, Inc..

What drugs are being tested in NCT03073824?

Interventions in NCT03073824: vSculpt.

What condition does NCT03073824 study?

NCT03073824 studies Pelvic Floor Disorders, Sexual Dysfunction, Stress Incontinence.

Is NCT03073824 still recruiting?

NCT03073824 is currently completed. Last updated 3 December 2018.

Last reviewed 2018-12-03 · How we verify

NCT03073824

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Long-term Evaluation of a Novel Intravaginal Device

Completed NA Last updated 3 December 2018

What this trial tests

NA trial testing vSculpt in Pelvic Floor Disorders in 65 participants. Completed in 29 November 2018.

Timeline

6 March 2017

Primary endpoint
29 November 2018

29 November 2018

Quick facts

Lead sponsor	Joylux, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	65
Start date	6 March 2017
Primary completion	29 November 2018
Estimated completion	29 November 2018
Sites	2 locations across United States

Drugs / interventions tested

vSculpt

Conditions studied

Pelvic Floor Disorders — all drugs for Pelvic Floor Disorders →
Sexual Dysfunction — all drugs for Sexual Dysfunction →
Stress Incontinence — all drugs for Stress Incontinence →

Sponsor

Joylux, Inc.

Who can join

Adults 30 to 59, female only, with Pelvic Floor Disorders or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An open-label long-term evaluation of a novel intravaginal device in female patients experiencing sexual and bladder function issues.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pelvic Floor Disorders

Currently open trials in the same condition.

NCT07268014 — Effects of Pelvic Exercises on Birth and Incontinence · NA · recruiting
NCT06986824 — Perineal Massage Using A Pelvic Wand During Pregnancy · Phase 4 · recruiting
NCT07004738 — Assessment of Rectus Abdominis Muscle Thickness and Residual Bladder Volume Before and After Pelvic Floor Exercises · NA · active not recruiting
NCT06796985 — Botox for Chronic Pelvic Pain · Phase 1 · recruiting
NCT06808542 — Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03073824 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joylux, Inc.
Last refreshed: 3 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03073824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing